Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Large Scale Clinical Chemistry and Immunochemistry Analyzer Launched in UK

By LabMedica International staff writers
Posted on 16 Nov 2009
A modular clinical chemistry and immunochemistry analyzer will provide the UK with large scale, high speed in vitro diagnostic (IVD) testing.

With a peak throughput of up to 8,400 tests per hour and 270 reagents on board, the cobas 8000 modular analyzer series merges the latest serum-work area technology with new process innovations. More...
It incorporates many new design elements such as module sample buffers and independent transport and processing lines for improved sample management. The convenient clinical chemistry reagent cassette with ready to-use reagents provides long on-board stability, and varying cassette sizes optimized for workflow and cost management.

Produced by Roche Diagnostics UK (Burgess Hill, UK), the cobas 8000 modular analyzer3 series is the newest member of the Roche cobas modular platform and combines clinical chemistry and immunochemistry testing. It is designed to enable high volume laboratories to deliver reliable results with optimal workflow and cost efficiency.

Tests run on the new platform provide the physician with important clinical information in a wide range of medical areas such as infectious and cardiac disease, bone disorders, and cancer. It also includes a range of novel biomarkers for maternal care and rheumatoid arthritis.

Roche Diagnostics has launched the cobas 8000 in the United Kingdom. This "hi-spec" instrument fills will provide the U.K. with large scale, high speed in vitro diagnostic (IVD) testing. This newest addition to the cobas family of integrated analyzers will allow extremely fast and efficient testing procedures and will significantly reduce sample turn-around.

"At Roche we are committed to creating true medical value through delivering leading edge diagnostic tests and technologies," said Ian Parfrement, director of hospital IVD at Roche. "The cobas 8000 modular analyzer series is a landmark technology which is uniquely designed to address the needs of high volume laboratories."

"The NHS demands greater flexibility for pathology testing to meet the overall aim of delivering improved patient care whilst responding to financial pressures," continued Parfrement. "With the introduction of the cobas 8000 as part of the overall Roche modular analyzer series, healthcare professionals are able to get the same consistent and highly accurate results no matter the testing environment."

The first configuration of cobas 8000 modular analyzer series to be launched is the high-speed clinical chemistry cobas c 701 module with up to 2000 tests per hour. In the coming months additional clinical chemistry and immunoassay modules will be introduced resulting in more than 38 scalable solutions which can be tailored to suit laboratories' current and future needs.

Related Links:
Roche Diagnostics UK



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.